BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 34831055)

  • 1. A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia.
    Bolandi SM; Pakjoo M; Beigi P; Kiani M; Allahgholipour A; Goudarzi N; Khorashad JS; Eiring AM
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
    Wang A; Zhong H
    Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
    Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
    Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia.
    Ladikou EE; Chevassut T; Pepper CJ; Pepper AG
    Br J Haematol; 2020 Jun; 189(5):815-825. PubMed ID: 32135579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bone marrow microenvironment - Home of the leukemic blasts.
    Shafat MS; Gnaneswaran B; Bowles KM; Rushworth SA
    Blood Rev; 2017 Sep; 31(5):277-286. PubMed ID: 28318761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Microenvironment in Resistance to Therapy in AML.
    Tabe Y; Konopleva M
    Curr Hematol Malig Rep; 2015 Jun; 10(2):96-103. PubMed ID: 25921386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Hypoxic Bone Marrow Microenvironment in Acute Myeloid Leukemia and Future Therapeutic Opportunities.
    Bruno S; Mancini M; De Santis S; Monaldi C; Cavo M; Soverini S
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-CXCL6 axis affects arteriolar niche remodeling in acute myeloid leukemia.
    Li L; Man J; Zhao L
    Exp Biol Med (Maywood); 2021 Jan; 246(1):84-96. PubMed ID: 33167688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells.
    Kouzi F; Zibara K; Bourgeais J; Picou F; Gallay N; Brossaud J; Dakik H; Roux B; Hamard S; Le Nail LR; Hleihel R; Foucault A; Ravalet N; Rouleux-Bonnin F; Gouilleux F; Mazurier F; Bene MC; Akl H; Gyan E; Domenech J; El-Sabban M; Herault O
    Oncogene; 2020 Feb; 39(6):1198-1212. PubMed ID: 31649334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities.
    Marchand T; Pinho S
    Front Immunol; 2021; 12():775128. PubMed ID: 34721441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dependence of acute myeloid leukemia on adhesion within the bone marrow microenvironment.
    Becker PS
    ScientificWorldJournal; 2012; 2012():856467. PubMed ID: 22346731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
    Lefort S; Maguer-Satta V
    Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice.
    Xiao P; Sandhow L; Heshmati Y; Kondo M; Bouderlique T; Dolinska M; Johansson AS; Sigvardsson M; Ekblom M; Walfridsson J; Qian H
    Blood Adv; 2018 Jun; 2(12):1480-1494. PubMed ID: 29945938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutically targeting SELF-reinforcing leukemic niches in acute myeloid leukemia: A worthy endeavor?
    Bernasconi P; Farina M; Boni M; Dambruoso I; Calvello C
    Am J Hematol; 2016 May; 91(5):507-17. PubMed ID: 26822317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming the Niche: The Emerging Role of Extracellular Vesicles in Acute Myeloid Leukaemia Progression.
    Mendes M; Monteiro AC; Neto E; Barrias CC; Sobrinho-Simões MA; Duarte D; Caires HR
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
    Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
    Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Bone Marrow Microenvironment on Leukemic Stem Cells: Breaking Up an Intimate Relationship.
    Agarwal P; Bhatia R
    Adv Cancer Res; 2015; 127():227-52. PubMed ID: 26093902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone Marrow Microenvironment as a Source of New Drug Targets for the Treatment of Acute Myeloid Leukaemia.
    Skelding KA; Barry DL; Theron DZ; Lincz LF
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Microenvironment in Acute Myeloid Leukemia: Adjusting Niches.
    Menter T; Tzankov A
    Front Immunol; 2022; 13():811144. PubMed ID: 35273598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemic stem cell signatures in Acute myeloid leukemia- targeting the Guardians with novel approaches.
    Thakral D; Gupta R; Khan A
    Stem Cell Rev Rep; 2022 Jun; 18(5):1756-1773. PubMed ID: 35412219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.